A bioactive intramedullary implant enables accelerated bone regeneration and early load-bearing in distraction osteogenesis
Acta Biomaterialia · 2026-09 · 222 · 636-650
DOI: 10.1016/j.actbio.2026.07.047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-09. Verfasst von Tomohiro Uno und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, School of Medicine, Stanford University, Stanford, California 94304, USA; Department of Orthopaedic Surgery, Yamag…. Hauptthemen laut MEDLINE: Bone Regeneration, Bone Morphogenetic Protein 2, Osteogenesis, Distraction, Implants, Experimental. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Distraction osteogenesis (DO) remains limited by prolonged consolidation and delayed bone union. This study evaluated whether a biodegradable, bone morphogenetic protein-2 (BMP-2)-releasing intramedullary implant (IMI) could enhance bone regenerate formation in a rat monofocal femoral lengthening model. We developed a Hybrid Tissue Engineering Construct (HyTEC) comprising a 3D-printed polycaprolactone-β-tricalcium phosphate IMI coated with a BMP-2-loaded hydrogel. Rats underwent standardized lengthening in three groups: control (DO only), IMI (implant without BMP-2), and IMI-BMP2 (BMP-2-releasing implant), with evaluation at postoperative days 31 and 52. The IMI-BMP2 group demonstrated significantly superior osteogenesis, achieving a bone volume fraction of 80 ± 22% at day 31, compared to 35 ± 19% (IMI) and 54 ± 25% (control), indicating accelerated regenerate formation. Radiographic and histological analyses confirmed early, uniform callus formation, while immunohistochemistry revealed elevated osteocalcin expression. Mechanical testing demonstrated restoration of approximately 50% of normal bone strength by day 52. Transcriptomic profiling revealed an exploratory BMP-2-associated regenerative gene signature, suggesting coordinated early-phase regulation of remodeling and metabolic reprogramming. This bioactive implant accelerated bone union, facilitated improved early ambulation consistent with partial mechanical competence restoration, and significantly shortened consolidation time, representing a promising clinically translatable strategy to overcome conventional DO limitations and improve patient outcomes. STATEMENT OF SIGNIFICANCE: Distraction osteogenesis is an effective strategy for managing large bone defects, but its clinical use is limited by prolonged consolidation and delayed functional recovery. This study presents a biodegradable intramedullary implant that provides sustained bone morphogenetic protein-2 (BMP-2) delivery and markedly accelerates regenerate formation, improves early mechanical strength, and enables earlier weight-bearing in a rat femoral lengthening model. In addition to demonstrating therapeutic efficacy, the work identifies a BMP-2-associated regenerative transcriptional signature linked to remodeling, osteoclast activity, and metabolic reprogramming. These findings establish a clinically translatable biomaterial-based approach to shorten treatment time and improve outcomes in distraction osteogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, School of Medicine, Stanford University, Stanford, California 94304, USA; Department of Orthopaedic Surgery, Yamagata University Faculty of Medicine, Yamagata, 9909585, Japan.
- Department of Orthopaedic Surgery, School of Medicine, Stanford University, Stanford, California 94304, USA; Department of Orthopedics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 8075…
- Department of Orthopaedic Surgery, School of Medicine, Stanford University, Stanford, California 94304, USA.
- Department of Bioengineering, School of Medicine, Stanford University, Stanford, California, 94305, USA.
- Department of Pathology, School of Medicine, Johns Hopkins University, Maryland 21218, USA.
- Department of Microbiology, Immunology, and Pathology, Colorado State University, Colorado 80523, USA.
Förderung
- NIAMS NIH HHS
- NCI NIH HHS
- National Institutes of Health
- US Department of War
Zitieren
APA
Uno, T., Lee, T. C., Shah, K., Chen, A. A. D., Lui, E., Alizadeh, H. V., Li, J., Muniz, R., Zhao, P., Pérez, A. S. F., Maekawa, H., Kim, S., Cherief, M., Regan, D. P., Takakubo, Y., Takagi, M., James, A., Young, J. L., Gardner, M. J., …, & Yang, Y. P. (2026). A bioactive intramedullary implant enables accelerated bone regeneration and early load-bearing in distraction osteogenesis. Acta Biomaterialia, 222, 636-650. https://doi.org/10.1016/j.actbio.2026.07.047
Vancouver
Uno T, Lee TC, Shah K, Chen AAD, Lui E, Alizadeh HV, et al. A bioactive intramedullary implant enables accelerated bone regeneration and early load-bearing in distraction osteogenesis. Acta Biomaterialia. 2026;222:636-650. doi:10.1016/j.actbio.2026.07.047
BibTeX
@article{Uno2026,
author = {Uno, Tomohiro and Lee, Tien-Ching and Shah, Krish and Chen, Anthony An-Fa Dahm and Lui, Elaine and Alizadeh, Hossein Vahid and Li, Jiannan and Muniz, Richard and Zhao, Peng and Pérez, Andrea Sofía Flores and Maekawa, Hirotsugu and Kim, Sungwoo and Cherief, Masnsen and Regan, Daniel P and Takakubo, Yuya and Takagi, Michiaki and James, Aaron and Young, Jeffrey L and Gardner, Michael J and Mohler, David G and Maloney, William J and Yang, Yunzhi Peter},
title = {A bioactive intramedullary implant enables accelerated bone regeneration and early load-bearing in distraction osteogenesis},
journal = {Acta Biomaterialia},
year = {2026},
volume = {222},
pages = {636--650},
doi = {10.1016/j.actbio.2026.07.047}
}
EUVIMED